Enzootic Bovine Leukosis

Enzootic Bovine Leukosis

Enzootic Bovine Leukosis (EBL) also known as Bovine lymphosarcoma, Leukemia and Malignant lymphoma.

Enzootic bovine leukosis (EBL) is a lympho-proliferative disease of cattle. It occurs in all breeds of both sexes.

Etiology

  • Enzootic Bovine Leukosis is caused by bovine leukemia virus (BLV)-Exogenous C-type oncogenic retrovirus of retroviridae.
  • The virus infects a subpopulation of B lymphocytes, and proviral DNA is integrated to a number of sites on the cellular DNA.

Transmission

  • Iatrogenic transmission occurs through  inoculation of small amounts of infected blood (e.g. infected needles, tattooing, dehorning and rectal palpation).
  • Vertical transmission from the dam to the calf (3–20 % of calves may become infected) and by colostrum or milk (less than 2 %).
  • Insect transmission is also a possibility; higher rates of infection were reported in the summer.

Pathogenesis

  •  Bovine leukosis is observed in two forms:
    • (a) Sporadic form – rare and occur in cattle below 3 yrs of age.
    • (b) Enzootic form- most common and occur in cattle over 3yrs of age.
  • Infections are usually subclinical; only 30–70% of infected cattle develop persistent lymphocytosis, and 0.1–10% of the infected animals develop tumours.
  • Signs will depend on the site of the tumours and may include digestive disturbances, inappetence, weight loss, weakness or general debility and sometimes neurological manifestation.

Clinical manifestation

  • Weight loss.
  • Laboured breathing due to heart involvement.
  • Persistent diarrhoea following infiltration of the abomasum wall by neoplastic cells.
  • Marked enlargement of several superficial lymph nodes.
  • Edema of the brisket and the intermandibular region.
  • Paralysis of the hind legs due to tumour compression of the spinal cord.
  • Protrusion of the eye as a result of tumour invasion of the orbital cavity.
  • Debilitation or emaciation.
  • Pale mucosal surface.
  • Bloated animal.
  • Swelling of the neck when thymus is involved.
  • Cutaneous nodules in the terminal stage.

Postmortem findings

  • Lymph node enlargement (clay-like consistency).
  • Enlargement of spleen (splenomegaly).
  • Thin watery blood.
  • Neoplastic lesions in the heart and intestines.
  • Enlarged haemolymph nodes.

Diagnosis

  • Based on clinical symptoms and lesions.
  • Virus can be detected in the culture supernatant following in-vitro culture of peripheral blood mononuclear cells (PBMC) from infected animals.
  • Proviral DNA can also be detected in PBMC or tumours of infected animals by PCR.
  • Detection of antibody by AGID  in serum.
  • Detection of antibody by ELISA in serum or milk of infected animals.

Differential diagnosis 

Treatment

  • Currently not available.

Prevention and control

  • Vaccine are not available for BLV.
  • Test and slaughter of seropositive animals in the herd.
  • Screening of antibodies in milk by ELISA.
  • Use single disposal gloves and needle to avoid transmission of disease through blood.
  • Cleaning and disinfection of dehorning and tattoo equipment and surgical instruments after use.
Scroll to Top